"Osteoporosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D010024
						 | 			
					
					
						| MeSH Number(s) | 
						
							 C05.116.198.579 C18.452.104.579 
						 | 
					
					
						| Concept/Terms | 
						
							Osteoporosis, Senile- Osteoporosis, Senile
 - Osteoporoses, Senile
 - Senile Osteoporoses
 - Osteoporosis, Involutional
 - Senile Osteoporosis
 
  Osteoporosis, Age-Related- Osteoporosis, Age-Related
 - Osteoporosis, Age Related
 - Bone Loss, Age-Related
 - Age-Related Bone Loss
 - Age-Related Bone Losses
 - Bone Loss, Age Related
 - Bone Losses, Age-Related
 - Age-Related Osteoporosis
 - Age Related Osteoporosis
 - Age-Related Osteoporoses
 - Osteoporoses, Age-Related
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Osteoporosis".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Osteoporosis".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Osteoporosis" by people in this website by year, and whether "Osteoporosis" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1995 | 1 | 2 | 3 | 
| 1997 | 1 | 1 | 2 | 
| 1998 | 0 | 1 | 1 | 
| 1999 | 0 | 2 | 2 | 
| 2000 | 1 | 0 | 1 | 
| 2001 | 1 | 0 | 1 | 
| 2002 | 2 | 1 | 3 | 
| 2003 | 0 | 2 | 2 | 
| 2004 | 4 | 2 | 6 | 
| 2005 | 3 | 1 | 4 | 
| 2006 | 3 | 0 | 3 | 
| 2007 | 2 | 0 | 2 | 
| 2008 | 1 | 1 | 2 | 
| 2009 | 0 | 1 | 1 | 
| 2010 | 0 | 2 | 2 | 
| 2011 | 0 | 1 | 1 | 
| 2012 | 1 | 4 | 5 | 
| 2013 | 2 | 1 | 3 | 
| 2014 | 5 | 0 | 5 | 
| 2015 | 4 | 4 | 8 | 
| 2016 | 3 | 1 | 4 | 
| 2017 | 3 | 1 | 4 | 
| 2018 | 1 | 1 | 2 | 
| 2019 | 4 | 1 | 5 | 
| 2020 | 3 | 0 | 3 | 
| 2021 | 5 | 1 | 6 | 
| 2022 | 10 | 0 | 10 | 
| 2023 | 3 | 0 | 3 | 
| 2024 | 1 | 5 | 6 | 
| 2025 | 2 | 1 | 3 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Osteoporosis" by people in Profiles.
						
					
								- 
								
Bone quality response to lifestyle intervention in older adults with obesity (LIMB-Q trial): a randomised controlled trial. Lancet Healthy Longev. 2025 Sep; 6(9):100761.
															
								 
							
								- 
								
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporos Int. 2025 Apr; 36(4):579-608.
															
								 
							
								- 
								
Prevalence of and risk factors for osteoporosis and fragility fracture in adults with cerebral palsy: A systematic review. Dev Med Child Neurol. 2025 May; 67(5):563-571.
															
								 
							
								- 
								
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clin Chem Lab Med. 2025 Mar 26; 63(4):704-711.
															
								 
							
								- 
								
Bone-targeted ultrasound-responsive nanobubbles for siRNA delivery to treat osteoporosis in mice. Biomater Adv. 2025 Jan; 166:214078.
															
								 
							
								- 
								
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects. Bone Res. 2024 Sep 05; 12(1):52.
															
								 
							
								- 
								
The Case for Bisphosphonate Use in Astronauts Flying Long-Duration Missions. Cells. 2024 08 13; 13(16).
															
								 
							
								- 
								
Protective Effects of ?-Blockers on Bone in Older Adults with Dementia. Calcif Tissue Int. 2024 Jul; 115(1):14-22.
															
								 
							
								- 
								
Genetic Evaluation for Monogenic Disorders of Low Bone Mass and Increased Bone Fragility: What Clinicians Need to Know. Curr Osteoporos Rep. 2024 Jun; 22(3):308-317.
															
								 
							
								- 
								
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis. Nat Commun. 2024 Mar 16; 15(1):2384.